Profile data is unavailable for this security.
About the company
Carl Zeiss Meditec AG is a Germany-based medical technology and device company. It offers offers complete solutions to diagnose and treat ophtalmic diseases, visualization solutions for microsurgery and other technologies, such as intraoperative radiotherapy. The Company operates in two segments: Ophthalmic Devices and Microsurgery. The Ophthalmic Devices segment comprises activities in the area of ophthalmology, such as intraocular lenses, surgical visualization solutions and medical laser and diagnostic systems. The Microsurgery segment includes activities of neuro, ear, nose and throat surgery, as well as the activities in the field of intraoperative radiation. The Company has various production sites in Europe, the United States and Asia.
- Revenue in EUR (TTM)2.09bn
- Net income in EUR276.75m
- Incorporated1995
- Employees4.82k
- LocationCarl Zeiss Meditec AGGoeschwitzer Strasse 51-52JENA 07745GermanyDEU
- Phone+49 3 641220331
- Fax+49 3 641220117
- Websitehttps://www.zeiss.de/meditec-ag/
Mergers & acquisitions
Acquired company | AFXX:GER since announced | Transaction value |
---|---|---|
DORC Dutch Ophthalmic Research Center (International) BV | 2.62% | 1.08bn |
Holder | Shares | % Held |
---|---|---|
DWS Investment GmbHas of 27 Mar 2024 | 1.86m | 2.08% |
Comgest SAas of 29 Dec 2023 | 1.83m | 2.04% |
Invesco Advisers, Inc.as of 29 Feb 2024 | 1.60m | 1.79% |
Norges Bank Investment Managementas of 31 Dec 2023 | 1.40m | 1.57% |
The Vanguard Group, Inc.as of 05 Apr 2024 | 1.30m | 1.45% |
Candriam Belgium SAas of 31 Mar 2024 | 889.09k | 0.99% |
Allianz Global Investors GmbHas of 31 Jan 2024 | 845.39k | 0.95% |
BlackRock Fund Advisorsas of 04 Apr 2024 | 647.20k | 0.72% |
BlackRock Asset Management Deutschland AGas of 05 Apr 2024 | 583.53k | 0.65% |
BlackRock Advisors (UK) Ltd.as of 04 Apr 2024 | 409.28k | 0.46% |